Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Abzena has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic inflammatory diseases.
read more
TCR2 Therapeutics has selected the advanced therapy medicinal products ecosystem in the United Kingdom (UK) to establish a site for global manufacturing systems and capabilities.
read more
Veeda Clinical Research announced their clinical (Shivalik, Ahmedabad) and Bioanalytical facilities (Insignia, Ahmedabad) have successfully completed the third inspection by NPRA.
read more
HitGen announced the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.
read more
HitGen announced the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.
read more
Diamond Pharma Services has announced that it provided EU regulatory support to Akcea, resulting in a positive CHMP opinion for the grant of a Conditional Marketing Authorization for WAYLIVRA Solution.
read more
Biofrontera has entered into an agreement to acquire all shares in Cutanea Life Sciences through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan as the seller.
read more
PCI has announced further investment to expand its flagship manufacturing center in Tredegar, Wales.
read more
Asymchem announced its Tianjin1 site successfully completed a FDA general GMP reinspection conducted between January 14-18, 2019. No Form 483 was issued.
read more
Thermo Fisher Scientific is investing $150 million in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
read more
PCI Pharma Services (PCI) announced Serge Dupuis has been appointed as Senior Vice President and Chief Financial Officer.
read more
WuXi Biologics has received EMA GMP certificates for the production of Trogarzo™ at its cGMP DS and DP manufacturing facilities in Wuxi city and its cGMP cell banking facilities in Shanghai.
read more
Paragon Bioservices has announced the appointment of Thomas VanCott, Ph.D., as Chief Technology and Strategy Officer (CTSO), along with several key promotions and new hires.
read more
STA Pharmaceutical announce a strategic partnership.
read more
Servier has entered into a collaborative study with Harvard University researchers to explore a new avenue for the treatment of type 2 diabetes and nonalcoholic fatty liver disease (NAFLD).
read more